Analytical Method Development of Benzisothiazolinone, a Biocide, Using LC–MS/MS and a Pharmacokinetic Application in Rat Biological Matrices
Molecules · 2023
DOI: 10.3390/molecules28020845 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Seong Jun Jo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Integrated Research Institute of Pharmaceutical Sciences, College of Pharmacy, The Catholic University of Korea, Bucheon 14662, Republic of Korea. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Disinfectants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Environment Industry & Technology Institute through Technology Program, Basic Science Research Program through the National Research Foundation of Korea, Research Fund of The Catholic University of Korea.
Abstract (Originalsprache)
Benzisothiazolinone (BIT), a biocide widely used as a preservative in household cleaning and personal care products, is cytotoxic to lung cells and a known skin allergen in humans, which highlights the importance of assessing its toxicity and pharmacokinetics. In this study, a simple, sensitive, and accurate LC–MS/MS method for the quantification of BIT in rat plasma, urine, or tissue homogenates (50 μL) using phenacetin as an internal standard was developed and validated. Samples were extracted with ethyl acetate and separated using a Kinetex phenyl–hexyl column (100 × 2.1 mm, 2.6 μm) with isocratic 0.1% formic acid in methanol and distilled water over a run time of 6 min. Positive electrospray ionization with multiple reaction monitoring transitions of m/z 152.2 > 134.1 for BIT and 180.2 > 110.1 for phenacetin was used for quantification. This assay achieved good linearity in the calibration ranges of 2–2000 ng/mL (plasma and urine) and 10–1000 ng/mL (tissue homogenates), with r ≥ 0.9929. All validation parameters met the acceptance criteria. BIT pharmacokinetics was evaluated via an intravenous and dermal application. This is the first study that evaluated BIT pharmacokinetics in rats, providing insights into the relationship between BIT exposure and toxicity and a basis for future risk assessment studies in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Integrated Research Institute of Pharmaceutical Sciences, College of Pharmacy, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
- Q-Fitter, Inc., Seoul 06578, Republic of Korea.
ORCID-Profile: Soo Hyeon Bae, Soo Kyung Bae
Förderung
- Korea Environment Industry & Technology Institute through Technology Program
- Basic Science Research Program through the National Research Foundation of Korea
- Research Fund of The Catholic University of Korea
- Technology Program for Establishing Biocide Safety Management
- National Research Foundation of Korea
Zitieren
APA
Jo, S. J., Huang, Z., Lee, C. B., Chae, S. U., Bae, S. H., & Bae, S. K. (2023). Analytical Method Development of Benzisothiazolinone, a Biocide, Using LC–MS/MS and a Pharmacokinetic Application in Rat Biological Matrices. Molecules. https://doi.org/10.3390/molecules28020845
Vancouver
Jo SJ, Huang Z, Lee CB, Chae SU, Bae SH, Bae SK. Analytical Method Development of Benzisothiazolinone, a Biocide, Using LC–MS/MS and a Pharmacokinetic Application in Rat Biological Matrices. Molecules. 2023. doi:10.3390/molecules28020845
BibTeX
@article{Jo2023,
author = {Jo, Seong Jun and Huang, Zhouchi and Lee, Chae Bin and Chae, Soon Uk and Bae, Soo Hyeon and Bae, Soo Kyung},
title = {Analytical Method Development of Benzisothiazolinone, a Biocide, Using LC–MS/MS and a Pharmacokinetic Application in Rat Biological Matrices},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28020845}
}
EUVIMED